BSX R&D to Revenue
Boston Scientific · R&D to Revenue
BSX R&D to Revenue
Latest reported10.22%period ending
BSX FY R&D/Revenue (0.00% → 10.22%)
Latest values, visible window
High-resolution chart · PNG
BSX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 10.2222% | |
| 9.6435% | |
| 9.9298% | |
| 10.4321% | |
| 10.1279% | |
| 11.5303% | |
| 10.9362% | |
| 11.3306% | |
| 11.019% | |
| 10.9707% | |
| 11.7159% | |
| 11.0705% | |
| 12.0538% | |
| 12.2224% | |
| 11.7423% | |
| 12.0292% | |
| 12.6038% | |
| 12.4099% | |
| 13.031% | |
| 12.8884% | |
| 10.8229% | |
| 10.1174% | |
| 13.0035% | |
| 11.7506% | |
| 10.2881% | |
| 7.47% | |
| 6.9317% | |
| 39.4968% | |
| 10.5058% | |
| 0% | |
| 0% | |
| 6.5716% | |
| 0% | |
| 0% | |
| 0% |